ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- 1 November 2021
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Radiology
- Vol. 18 (11), S502-S515
- https://doi.org/10.1016/j.jacr.2021.09.005
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Evaluation of Screening Whole‐Breast Sonography as a Supplemental Tool in Conjunction With Mammography in Women With Dense BreastsJournal of Ultrasound in Medicine, 2013
- A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormonesActa Endocrinologica, 2011
- Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA TrialJournal of Clinical Oncology, 2010
- Multimodality Screening of High-Risk Women: A Prospective Cohort StudyJournal of Clinical Oncology, 2009
- Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast CancerJAMA, 2008
- Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionCancer, 2006
- Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast CancerJournal of Clinical Oncology, 2005
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998